
NHS nurse punished for calling transgender paedophile ‘Mr'
An NHS nurse was punished after accidentally addressing a transgender paedophile as 'Mr'.
The paedophile, a patient from a high-security men's prison, called Jennifer Melle, 40, a 'n-----' three times during an aggressive tirade at St Helier Hospital in Carshalton, Surrey.
But it was Ms Melle who was investigated and disciplined by the hospital in October 2024, with a final warning and a referral to the Nursing and Midwifery Council.
Now she is filing a legal claim against the Epsom and St Helier University Hospitals Trust for harassment, discrimination and human rights breaches.
Ms Melle said: 'Ever since I have expressed my Christian beliefs under extreme pressure, I have been a marked woman.'
Last year, the patient, known only as Patient X, arrived from a men's prison at Ms Melle's ward to receive treatment for a urinary problem.
During the evening shift, a colleague told Ms Melle, the senior nurse on staff, that the patient wanted to self-discharge and a doctor was called for guidance.
Ms Melle spoke with the doctor on the phone outside the patient's room, during which Ms Melle referred to the patient as 'mister' and 'he'.
She said she was discussing a catheter, for a male person, which needed to be removed, adding: 'This was a real-life medical scenario that required accurate terminology to avoid any doubt between medical professionals.'
Overhearing Ms Melle, the patient who was born a man but identified as a woman, took issue with the male pronoun and title.
The nurse replied that she was 'sorry I cannot refer to you as 'her' or 'she', as it's against my faith and Christian values but I can call you by your name.'
The patient began to verbally abuse the nurse, saying: 'Imagine if I called you n-----? How about I call you n-----? Yes, black n------.'
The patient also lunged at her despite being restrained and threatened to make a complaint, she said.
Ms Melle said: 'It was terrifying. I'd never been called that word before. And I thought I was going to be attacked.'
Last month, Ms Melle received a letter from the Nursing and Midwifery Council, which is assessing her ability to practise.
Its code of conduct states nurses should 'not express your personal beliefs (including political, religious or moral beliefs) in an inappropriate way. Therefore, although [Ms Melle] felt unable to identify Patient X using the preferred pronouns due to her religion... it could be perceived that [Ms Melle's] actions could…be seen as a potential breach of the code'.
Ms Melle has denied there was any breach of the code and said that a white colleague also referred to the patient as a male but suffered no abuse or investigation.
She said: 'My conduct throughout this incident and during my career has been fully compliant with the code.
'I have been put at risk, but I am being treated like a criminal. Sadly, if you put your head above the parapet and speak truthfully on these issues in the NHS, the risk is that you will be knocked down, punished severely and demoted.'
NHS 'captured by transgender ideology'
Christian Legal Centre is supporting Ms Melle's legal claim.
Andrea Williams, the centre's chief executive, said: 'The NHS appears to remain captured by transgender ideology to the point it is prepared to back a convicted paedophile, who was clearly very disturbed and shouting racist comments, over the Christian nurse.
'Jennifer Melle was genuinely doing her best while not wanting to deny her Christian faith and biological reality.
'We would ask Wes Streeting, as health secretary, to investigate what is happening here. He is already involved in the Darlington nurses' case, and has previously said he is 'horrified' by how they are being treated. It's time for government intervention on this matter.'
Eight nurses at Darlington Memorial Hospital are suing the County Durham and Darlington NHS Foundation Trust, their employer, for sexual discrimination and sexual harassment after Rose Henderson, a transgender nurse, was allowed to use a female changing room.
A spokesman for Epsom and St Helier University Hospitals NHS Trust said: 'These matters are still subject to ongoing internal proceedings, so it wouldn't be right for us to comment further.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mirror
an hour ago
- Daily Mirror
UKHSA issues urgent health warning after walking outdoors
People have been urged to look out for ticks, small creatures that can carry a number of infections. Brits have been issued an urgent warning to take care when walking outdoors this summer due to a serious risk to health. The UK Health Security Agency (UKHSA) has shared guidance on how to stay safe from ticks. Ticks are tiny, spider-like creatures that live in undergrowth and latch on to animals including humans when they walk through long grass. They are becoming more prevalent in parts of the UK, mainly due to increasing numbers of deer. While feeding, they can transmit viruses and infections that cause disease, with the most common being Lyme disease. In a post made to X, the UKHSA said: 'Summer's a great time to get outside, but ticks love the outdoors too. 'If you're walking through grassy or wooded areas, take a look at our guidance to help you stay safe and be tick aware.' In an infographic, it explained what to do if you find a tick on your body. What to do if you've been bitten by a tick 'Remove ticks as soon as you find them,' it said. 'If you have a tick removal device, follow its instructions or use a pair of fine-tipped tweezers.' Next you need to grasp the tick 'as close to the skin as you can'. The UKHSA explained: 'Pull upwards firmly, making sure all of the tick is removed.' You then need to clean the bite area with soap and water, and keep an eye on it for a few weeks in case of 'any changes' The health authority warned: 'Look out for a spreading bullseye rash, which is a common symptom of Lyme disease three to 30 days after being bitten. 'If you become unwell, for example with a spreading circular rash, flu-like symptoms, nerve pain or a droop on one or both sides of the face within a few weeks of a tick bite, call your GP practice or NHS 111.' Other potential symptoms of Lyme disease include: A high temperature, or feeling hot and shivery Headache Muscle and joint pain Tiredness and loss of energy The NHS warns that some people who are diagnosed and treated for Lyme disease continue to have symptoms, like tiredness, aches and loss of energy, that can last for years. 'These symptoms are often compared to fibromyalgia and chronic fatigue syndrome,' it says. 'It's not clear why this happens to some people and not others. This means there's also no agreed treatment.' You should speak to a doctor if your symptoms come back, or do not improve, after treatment with antibiotics. To reduce the risk of being bitten by a tick in the first place, the NHS recommends you:


The Independent
an hour ago
- The Independent
Thousands of NHS patients ‘to be denied breakthrough Alzheimer's drugs'
Breakthrough drugs that slow the progression of Alzheimer's disease will reportedly be refused for use on the NHS this week in a blow to thousands of patients. The two drugs, Lecanemab and donanemab, slow down the decline in Alzheimer's patients' ability to carry out daily activities. The drugs' success in halting the progression of Alzheimer's was heralded as a 'new era' by campaigners and researchers. However, the National Institute for Health and Care Excellence (Nice) is expected to refuse to recommend them on the NHS, according to The Sunday Times. The regulator has already issued two decisions, one in October last year and another in March, saying they would not recommend the drugs for use on the NHS. A final decision will be published on Thursday. Both drugs already have UK drug licences, making them available privately. It is estimated that around 70,000 adults in England would have been eligible for treatment if the drugs had been approved. The regulator will reportedly turn down both drugs on the grounds of cost-effectiveness, with one insider telling The Sunday Times: 'It is the end of the road for these drugs on the NHS'. Lecanemab removes build-ups of the protein beta-amyloid from the brain. Trials showed that lecanemab can slow the progression of Alzheimer's by 27 per cent over 18 months if given to someone early on in the course of their decline. Donanemab, marketed as Kisunla in the UK, teaches the body's immune cells to recognise and remove the amyloid protein, which builds up in the brains of people with Alzheimer's disease. The protein build-ups are thought to be toxic to brain cells, leading to the symptoms of Alzheimer's, the Alzheimer's society has said. Lecanemab can, however, cause swelling and bleeding in the brain. In trials for Donanemab, a third of recipients experienced abnormalities in their brain scans caused by brain swelling and bleeding, NICE said. The drugs reportedly cost around £20,000 to £25,000, with the NHS being offered a lower price. Privately, the treatment costs between £60,000-80,000 per year, according to Alzheimer's Research UK. In a previous review by NICE in October 2024, director of medicines evaluation Helen Knight said: 'Donanemab could slow down cognitive decline by 4-7 months, but this is just not enough benefit to justify the additional cost to the NHS. The cost-effectiveness estimate for donanemab is five to six times above what NICE normally considers an acceptable use of NHS resources'. While the regulator said the decision would be disappointing for some, 'there are other treatments being developed'. Hilary Evans-Newton, chief executive of Alzheimer's Research UK, said the decision to turn down the drugs would be 'deeply disappointing'. She added: 'These treatments are not perfect, and we recognise the challenges they pose around cost, delivery and safety. But scientific progress is incremental, and these drugs represent a vital foundation to build on.' The regulator NICE is due to publish the final draft guidance about the two drugs on Thursday. This leaves space for the decision to be challenged and sent to a review panel before the final guidance is published.


BBC News
2 hours ago
- BBC News
Herne Bay man has bladder tumours treated as NHS outpatient
A father-of-four has had bladder tumours removed as an outpatient at a Kent hospital through a pioneering new Payne, from Herne Bay, watched on-screen as surgeons removed a small tumour from his bladder via a procedure known as trans urethral laser 67-year-old, who underwent the procedure last week at Kent and Canterbury Hospital, says he was "absolutely blown over by the experience and the technology".Mr Payne had a previous tumour removed under general anaesthetic four years ago at an East Kent Hospitals University NHS Foundation Trust hospital. He said he was "a little bit nervous" before undergoing the new procedure, as he feared it might not be as effective."But it was exactly the same, just without the general anaesthetic," he said."I watched it on screen. I could see everything, and it was just like watching a documentary. I was even able to direct the consultant to where the tumour was." 'Major step forward' The procedure saw lead consultant for superficial bladder cancer, Georgios Papadopoulos, insert a thin flexible tube with a camera and light into Mr Payne's then took biopsies of the tumour before it was removed using a laser. Any remaining cancer cells were killed using chemotherapy. Mr Papadopoulos said: "This is a major step forward in how we treat patients with small tumours in their bladder."The Prostate Cancer Support Association Kent donated two laser machines, while the League of Friends of the Kent and Canterbury Hospital also helped provide funding.